Synthesis of new pyrazolothiazole derivatives from 4-thiazolidinones

Article abstract of DOI:10.3390/12092151

The synthesis of new 2,3,5,6-aryl substituted tetrahydro-2H-pyrazolo[3,4-d] -thiazoles 4a-j as potential biologically active compounds by the cyclocondensation of phenyl hydrazine with new 5-arylidene derivatives 2a-j of 2,3-disubstituted-1,3-thiazolidin-

Full text of DOI:10.3390/12092151

Molecules 2007, 12, 2151-2159
molecules
ISSN 1420-3049
© 2007 by MDPI
www.mdpi.org/molecules
Full Paper
Synthesis of New Pyrazolothiazole Derivatives from
4-Thiazolidinones
Zuhal Turgut *, Cigdem Yolacan, Feray Aydogan, Emine Bagdatli and Nuket Ocal
Yildiz Technical University, Faculty of Arts and Sciences, Department of Chemistry, Davutpasa
Campus, Esenler, 34210, Istanbul, Turkey
* Author to whom correspondence should be addressed; E-mail: zturgut@yildiz.edu.tr
Received: 11 August 2007; in revised form: 2 September 2007 / Accepted: 3 September 2007 /
Published: 6 September 2007
Abstract: The synthesis of new 2,3,5,6-aryl substituted tetrahydro-2H-pyrazolo[3,4-d]-
thiazoles 4a-j as potential biologically active compounds by the cyclocondensation of
phenyl hydrazine with new 5-arylidene derivatives 2a-j of 2,3-disubstituted-1,3-
thiazolidin-4-ones 1a-e is reported.
Keywords: Cyclizations, heterocycles, fused thiazolidines
Introduction
Small ring heterocycles containing nitrogen, sulfur and oxygen have been under investigation for a
long time because of their important medicinal properties. Among these type of molecules,
4-thiazolidinones have been shown to have various important biological activities such as
antibacterial, antifungal, antiviral, diuretic, antituberculostatic, anti-HIV, antihistaminic, anticancer,
anticonvulsant, antiinflammatory and analgesic properties [1-5].
We have already reported some of our work on the synthesis, transformations and some biological
properties of various 4-thiazolidinones [6-9]. Some of these compounds were screened for their
antibacterial and antituberculostatic activities, and it has been found that some of them have moderate
to good biological properties [8]. The biological significance of this class of compounds impelled us to
continue working on the synthesis of new thiazolidine derivatives. In this study we report the synthesis

Molecules 2007, 12
2152
of some new tetrahydro-2H-pyrazolo[3,4-d]thiazole derivatives starting from various 4-
thiazolidinones.
Results and Discussion
The target compounds were prepared starting from 4-thiazolidinone derivatives. In the first step,
4-thiazolidinones 1a-e were synthesized by the Katti carbodiimide (DCC) mediated one-pot three-
component condensation reaction of an aromatic amine, an aldehyde and a mercaptoacetic acid [10]
(Scheme 1).
Scheme 1. Synthesis of 4-thiazolidinones 1a-e.
H3CO
H3CO
OCH3
X
O
O
H
DCC / THF
-2H2O
H3CO
H3CO
+
X
NH2
+
HS
OH
H3CO
N
S
O
1 a-e
(X= a, CH3; b, Cl; c, OC6H5; d, OCH3; e, OC2H5)
Then compounds 1a-e were reacted with 4-chlorobenzaldehyde and 4-dimethylaminobenzaldehyde
in the presence of sodium ethoxide to afford the new 5-benzylidene derivatives 2a-j (Scheme 2). Next,
compounds 2a-j condensed with phenyl hydrazine in glacial acetic acid in the presence of sodium
acetate to give products 4a-j (Scheme 2). In a typical reaction, 5-benzylidene derivatives, sodium
acetate and phenyl hydrazine were refluxed for 7-8 h in glacial acetic acid. The crude reaction mixture
was filtered hot to remove any insoluble material, and cooled. Water was added to the resulting
mixture which was boiled for a few minutes. Finally, the mixture was cooled to afford the crude
product which was then purified by column chromatography using the appropriate solvent system.
Compounds 4a-j are presumably formed by way of the phenyl hydrazones 3, followed by cyclization
and proton transfer.
The structures of the new compounds were assigned on the basis of their analytical and spectral
1
data. Compounds 1a-e display in their H-NMR spectra, in addition to other signals, doublets at δ
3.81-3.99 ppm due to the HA and HB system. In the benzylidene derivatives 2a-j, this AB system was
absent, confirming that condensation had been taken place. Regarding compounds 4a-j, their 1H-NMR
spectra showed two doublets at δ 5.79 - 5.82 ppm due to a proton on 3a-CH and at 4.52 - 4.58 ppm,
due to a proton on 3-CH, respectively. These signals demonstrate that the cyclization step had
occurred.
Characteristic C=O bands appeared in the 1702-1682 cm-1 region in the FT-IR spectra of the
thiazolidinones 1a-e and benzylidene derivatives 2 a-j. In the FT-IR spectra of compounds 4a-j, the
amide carbonyl band was absent, which clearly confirmed that a cyclocondensation with phenyl
hydrazine had been taken place. Besides, the C=N bands of 4a-j were observed in the 1596-1602 cm-1

Molecules 2007, 12
2153
region. Although the new compounds have stereogenic centers, we were not able to separate the
diastereomers due to their similar Rf values.
Scheme 2. Synthesis of 5-arylidene-4-thiazolidinones 2a-j and
tetrahydro-2H-pyrazolo-[3,4-d]thiazoles 4 a-j.
OCH3
H3CO
OCH3
O
C2H5ONa
-H2O
1 a-e
Y
+
Y
S
H
N
X
Y= Cl, N(CH3)2
O
2 a-j
(2 a-e; Y= Cl; X= a, CH3; b, Cl; c, OC6H5; d, OCH3; e, OC2H5)
(2 f-j; Y= N(CH3)2; X= f, CH3; g, Cl; h, OC6H5; i, OCH3; j, OC2H5)
PhNHNH2
-H2O
H3CO
OCH3
H3CO
OCH3
Y
OCH3
OCH3
S
CH3COONa
S
Y
N
N
X
N
X
N
N
HN
4 a-j
3
(4 a-e; Y= Cl; X= a, CH3; b, Cl; c, OC6H5; d, OCH3; e, OC2H5)
(4 f-j; Y= N(CH3)2; X= f, CH3; g, Cl; h, OC6H5; i, OCH3; j, OC2H5)
Our results have shown that the sequential condensation of phenyl hydrazine and compounds 2a-f
containing carbonyl functionalities is a useful reaction for the construction of novel heterocycles of
possible pharmacological interest.
Experimental
General
NMR spectra were recorded on a 400 MHz Bruker Digital FT-NMR ‘Avance 400’ spectrometer.
Chemical shifts (δ) are on parts per million (ppm), with CDCl3 as solvent and relative to

Molecules 2007, 12
2154
tetramethylsilane (TMS) as the internal reference. FT-IR spectra were recorded on Perkin Elmer FT-IR
spectrometer (KBr pellets). GC-EIMS spectra were measured on a Varian SAT2100T mit GC3900
spectrometer using ionization by FAB. Melting points were measured on a Gallenkamp melting point
apparatus. Silica gel 60 (Merck) was used for column separations. TLC was conducted on standard
conversion aluminium sheets pre-coated with a 0.2 mm layer of silica gel. Elemental analyses were
measured with a Thermo Flash Flash EA 1112 Series apparatus.
General procedure for the synthesis of 4-thiazolidinones 1a-e
p-Substituted aniline (1 mmol) and 3,4,5-trimethoxybenzaldehyde (2 mmol) were stirred in THF
at an ice-bath for 5 min, followed by addition of mercaptoacetic acid (3 mmol). After 5 min DCC (1.2
mmol) was added to the reaction mixture at 0°C and the reaction mixture stirred for additional 1-3
hours at room temperature. Formed DCU was removed by filtration, filtrate was concentrated to
dryness under reduced pressure and the residue was taken up with ethyl acetate. The organic layer was
washed with 5 % aq. citric acid, water, 5 % aq. sodium hydrogen carbonate and then with brine. The
organic layer was dried over sodium sulfate and the solvent removed under vacuum to give the crude
product, which was purified by recrystallization from 2:1 petroleum ether-diethyl ether.
2-(3,4,5-Trimethoxyphenyl)-3-(4-methylphenyl)-4-thiazolidinone (1a). Light yellow crystals; yield 59
%; mp. 161 oC; 1H-NMR δ: 2.29 (s, 3H, CH3), 3.78 (s, 9H, OCH3), 3.87, 3.93 (AB system, J= 9.2 Hz,
2H, 5-CH2), 6.47 (s, 1H, 2-CH), 7.01-7.38 (m, 6H, aromatic); FT-IR: 1702 (N-C=O) cm-1; Anal. Calcd
for C19H21NO4S (359.12): C: 63.49; H, 5.89; N, 3.90; S, 8.92. Found: C, 63.59; H, 5.92; N, 3.84; S,
8.89; MS: m/z 359.
3-(4-Chlorophenyl)-2-(3,4,5-trimethoxyphenyl)-4-thiazolidinone (1b). Yellow crystals, yield 52 %;
mp. 161-162 oC; 1H-NMR δ: 3.78 (s, 9H, OCH3), 3.86, 3.91 (AB system, J= 9.2 Hz, 2H, 5-CH2), 6.01
(s, 1H, 2-CH), 6.57-7.33 (m, 6H, aromatic) ppm; FT-IR: 1682 (N-C=O) cm-1; Anal. Calcd for
C18H18ClNO4S (379.86): C, 56.91, H: 4.77, N: 3.68, S: 8.44. Found: C:56.89, H: 4.79, N: 3.70, S: 8.47;
MS: m/z 380.
2-(3,4,5-Trimethoxyphenyl)-3-(4-phenoxyphenyl)-4-thiazolidinone (1c). Light yellow crystals, yield 73
o
1
%; mp. 141-142 C; H-NMR δ: 3.78 (s, 9H, OCH3), 3.86, 3.93 (AB system, J= 9.1 Hz, 2H, 5-CH2),
5.96 (s, 1H, 2-CH), 6.47-7.33 (m, 11H, aromatic) ppm; FT-IR: 1683 (N-C=O) cm-1; Anal. Calcd. for
C24H23 NO5S (437.51): C: 65.88; H: 5.30; N: 3.20; S: 7.33. Found: C: 65.89, H: 5.29, N: 3.22, S: 7.36;
MS: m/z 438.
3-(4-Methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-4-thiazolidinone (1d). Light yellow crystals, yield 68
o
1
%; mp. 144-145 C; H-NMR δ: 3.64 (s, 3H, OCH3), 3.78 (s, 9H, OCH3), 3.81, 3.93 (AB system, J=
9.2 Hz, 2H, 5-CH2), 5.91 (s, 1H, 2-CH), 6.47-7.24 (m, 6H, aromatic) ppm; FT-IR: 1685 (N-C=O) cm-1;
Anal. Calcd. for C19H21NO5S (375.44): C: 60.78, H: 5.64, N: 3.73, S: 8.54. Found: C: 60.81, H: 5.67,
N: 3.76, S: 8.58, MS: m/z 375.

Molecules 2007, 12
2155
3-(4-Ethoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-4-thiazolidinone (1e). Light yellow crystals, yield 69
%; mp. 156-157 oC; 1H-NMR δ: 1.23-1.36 (t, J= 7.2 Hz, 3H, CH3), 3.77 (s, 9H, OCH3), 3.81-3.99 (m,
4H, 5-CH2, OCH2), 5.91 (s, 1H, 2-CH), 6.38-7.33 (m, 6H, aromatic) ppm; FT-IR: 1702 (N-C=O) cm-1;
Anal. Calcd. for C20H23NO5S (389.47): C: 61.68, H: 5.95, N: 3.60, S: 8.23. Found: C: 61.70, H: 5.97,
N: 3.63, S: 8.25, MS: m/z 389.
General procedure for the preparation of 5-arylidine-4-thiazolidinones 2a-j
A solution of 1a-e (1 mmol) and 4-chlorobenzaldehyde (1 mmol) or 4-dimethylaminoaniline (1
mmol) in dry benzene (25 mL) was refluxed for about 10-12 h, in the presence of sodium ethoxide (1
mmol), cooled, poured into ice cold water and then acidified with glacial acetic acid. The benzene
layer was separated, dried over CaCl2 and evaporated in vacuo to give crude product that was purified
by recrystallization.
5-(4-Chlorobenzylidene)-2-(3,4,5-trimethoxyphenyl)-3-(4-methylphenyl)-4-thiazolidinone
(2a).
Orange crystals; yield 53 %; mp. 174 oC (from petroleum ether-diethyl ether, 4:1); 1H-NMR δ: 2.29 (s,
3H, CH3), 3.74 (s, 9H, OCH3), 6.46 (s, 1H, =CH), 6.74-6.83 (m, 4H, aromatic), 7.18-7.43 (m, 3H,
aromatic and 2-CH), 7.51-7.53 (m, 2H, aromatic), 7.64-7.77 (m, 2H, aromatic) ppm; FT-IR: 1683 (N-
C=O) cm-1; Anal. Calcd. for C26H24ClNO4S (481.11): C: 64.79, H: 5.02; N: 2.91, S: 6.65. Found: C:
64.74, H: 5.07; N: 2.94, S: 6.61; MS: m/z 481.
5-(4-Chlorobenzylidene)-3-(4-chlorophenyl)-2-(3,4,5-trimethoxyphenyl)-4-thiazolidinone (2b). Red-
o
1
dish crystals; yield 41 %; mp. 184-186 C (from petroleum ether-diethyl ether, 4:1); H-NMR δ: 3.78
(s, 9H, OCH3), 6.46 (s, 1H, =CH), 6.96-7.21 (m, 4H, aromatic), 7.33-7.51 (m, 3H, aromatic and 2-CH),
7.63-7.66 (m, 2H, aromatic), 7.83-7.87 (m, 2H, aromatic) ppm; FT-IR: 1691 (N-C=O) cm-1; Anal.
Calcd. for C25H21Cl2 NO4S (502.45): C: 59.77, H: 4.21, N: 2.79, S: 6.38. Found: C: 59.80, H: 4.23, N:
2.81, S: 6.40; MS: m/z 502.
5-(4-Chlorobenzylidene)-2-(3,4,5-trimethoxyphenyl)-3-(4-phenoxyphenyl)-4-thiazolidinone (2c). Dark
o
1
orange crystals; yield 44 %; mp. 168-170 C (from petroleum ether-diethyl ether, 3:1); H NMR
(CDCl3) δ: 3.78 (s, 9H, OCH3), 6.52 (s, 1H, =CH), 6.96-7.15 (m, 8H, aromatic), 7.18-7.29 (m, 4H,
aromatic and 2-CH), 7.63-7.66 (m, 2H, aromatic), 7.83-7.87 (m, 2H, aromatic) ppm; FT IR (KBr):
1685 (N-C=O) cm-1; Anal. Calcd. for C31H26ClNO5S (560.06): C: 66.48, H: 4.79, N: 2.50, S: 5.72.
Found: C: 66.50, H: 4.81, N: 2.51, S: 5.75; MS: m/z 560.
5-(4-Chlorobenzylidene)-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-4-thiazolidinone
(2d).
o
1
Orange crystals; yield 48 %; mp. 181-182 C (from petroleum ether-diethyl ether, 4:1); H-NMR δ:
3.63 (s, 3H, OCH3), 3.79 (s, 9H, OCH3), 6.47 (s, 1H, =CH), 6.96-7.09 (m, 4H, aromatic), 7.19-7.52 (m,
3H, aromatic and 2-CH), 7.63-7.67 (m, 2H, aromatic), 7.83-7.86 (m, 2H, aromatic) ppm; FT-IR: 1689
(N-C=O) cm-1; Anal. Calcd. for C26H24ClNO5S (497.99): C: 62.71, H: 4.86, N: 2.81, S: 6.44. Found:
C: 62.74, H: 4.87, N: 2.81, S: 6.47; MS: m/z 498.

Molecules 2007, 12
2156
5-(4-Chlorobenzylidene)-3-(4-ethoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-4-thiazolidinone (2e). Orange
crystals; yield 51 %; mp. 173 oC (from petroleum ether-diethyl ether, 3:1); 1H-NMR δ: 1.22-1.36 (t, J=
7.2 Hz, 3H, CH3), 3.78 (s, 9H, OCH3), 3.93-3.97 (q, J= 7.2 Hz, 2H, OCH2), 6.45 (s, 1H, =CH), 6.94-
7.11 (m, 4H, aromatic), 7.19-7.53 (m, 3H, aromatic and 2-CH), 7.63-7.68 (m, 2H, aromatic), 7.83-7.85
(m, 2H, aromatic) ppm; FT-IR: 1687 (N-C=O) cm-1; Anal. Calcd. for C27H26ClNO5S (512.02): C:
63.33, H: 5.12, N: 2.73, S: 6.26. Found: C: 63.36, H: 5.15, N: 2.75, S: 6.29; MS: m/z 512.
5-(4-Dimethylaminobenzylidene)-2-(3,4,5-trimethoxyphenyl)-3-(4-methylphenyl)-4-thiazolidinone (2f).
o
1
Yellow crystals; yield 42 %; mp. 162 C (from petroleum ether-diethyl ether, 4:1); H- NMR δ: 2.31
(s, 3H, CH3), 3.05 (s, 6H, CH3), 3.76 (s, 9H, OCH3), 6.42 (s, 1H, =CH), 6.76-7.22 (m, 4H, aromatic),
7.29-7.38 (m, 3H, aromatic and 2-CH), 7.45-7.49 (m, 2H, aromatic), 7.77-7.81 (m, 2H, aromatic) ppm;
FT-IR: 1683 (N-C=O) cm-1; Anal. Calcd. for C28H30N2O4S (490.62): C: 68.55, H: 6.16, N: 5.71, S:
6.53. Found: C: 68.56, H: 6.19, N: 5.73, S: 6.58; MS: m/z 491.
3-(4-Chlorophenyl)-5-(4-dimethylaminobenzylidene)-2-(3,4,5-trimethoxyphenyl)-4-thiazolidinone (2g).
o
1
Red crystals; yield 32 %; mp. 156-157 C (from petroleum ether-diethyl ether, 3:1); H-NMR δ: 3.05
(s, 6H, CH3), 3.78 (s, 9H, OCH3), 6.42 (s, 1H, =CH), 6.87-6.94 (m, 4H, aromatic), 7.18-7.22 (m, 3H,
aromatic and 2-CH), 7.33-7.37 (m, 2H, aromatic), 7.47-7.50 (m, 2H, aromatic) ppm; FT-IR: 1684 (N-
C=O) cm-1; Anal. Calcd. for C27H27 ClN2O4S (511.04): C: 63.46, H: 5.32, N: 5.48, S: 6.27. Found: C:
63.49, H: 5.33, N: 5.50, S: 6.31; MS: m/z 511.
5-(4-Dimethylaminobenzylidene)-2-(3,4,5-trimethoxyphenyl)-3-(4-phenoxyphenyl)-4-thiazolidinone
o
1
(2h). Orange crystals; yield 31 %; mp. 152 C (from petroleum ether-diethyl ether, 2:1); H-NMR δ:
3.02 (s, 6H, CH3), 3.81 (s, 9H, OCH3), 6.43 (s, 1H, =CH), 6.92-7.05 (m, 8H, aromatic), 7.17-7.23 (m,
3H, aromatic), 7.39-7.52 (m, 3H, aromatic and 2-CH), 7.63-7.71 (m, 2H, aromatic) ppm; FT-IR: 1691
(N-C=O) cm-1; Anal. Calcd. for C33H32 N2O5S (568.69): C: 69.71, H: 5.67, N: 4.93, S: 5.63. Found: C:
69.74, H: 5.69, N: 4.97, S: 5.67; MS: m/z 569.
5-(4-Dimethylaminobenzylidene)-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-4-thiazolidinone
(2i). Orange crystals; yield 43 %; mp. 156-158 oC (from petroleum ether-diethyl ether, 2:1); 1H-NMR
δ: 3.02 (s, 6H, CH3), 3.59 (s, 3H, OCH3), 3.81 (s, 9H, OCH3), 6.47 (s, 1H, =CH), 6.82-7.09 (m, 4H,
aromatic), 7.19-7.53 (m, 3H, aromatic and 2-CH), 7.63-7.68 (m, 2H, aromatic), 7.78-7.81 (m, 2H,
aromatic) ppm; FT-IR: 1691 (N-C=O) cm-1; Anal. Calcd. for C28H30N2O5S (506.62): C: 66.38, H: 5.97,
N: 5.53, S: 6.33. Found: C: 66.41, H: 5.99, N: 5.56, S: 6.37; MS: m/z 507.
5-(4-Dimethylaminobenzylidene)-3-(4-ethoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-4-thiazolidinone (2j).
o
1
Orange crystals; yield 36 %; mp. 162 C (from petroleum ether-diethyl ether, 4:1); H- NMR δ: 1.24-
1.38 (t, J= 7.2 Hz, 3H, CH3), 3.01 (s, 6H, CH3), 3.81 (s, 9H, OCH3), 3.91-3.95 (q, J= 7.2 Hz, 2H,
OCH2), 6.43 (s, 1H, =CH), 6.94-7.15 (m, 4H, aromatic), 7.23-7.49 (m, 3H, aromatic and 2-CH), 7.58-
7.62 (m, 2H, aromatic), 7.77-7.81 (m, 2H, aromatic) ppm; FT-IR: 1682 (N-C=O) cm-1; Anal. Calcd.
for C29H32N2O5S (520.65): C: 66.91, H: 6.20, N: 5.38, S: 6.16. Found: C: 66.95, H: 6.22, N: 5.41, S:
6.19; MS: m/z 521.

Molecules 2007, 12
2157
General method for tetrahydro-2H-pyrazolo[3,4-d]thiazoles 4a-j
The respective benzylidene derivative, 2a-j (1 mmol) in glacial acetic acid (10 mL), sodium acetate
(1 g) and phenyl hydrazine (1 mL) were heated for 7 h. The mixture was filtered hot to remove any
insoluble material, cooled, and then water was added and boiled for few minutes, then it was cooled to
afford the crude product which was purified by column chromatography from n-hexane-ethyl acetate
(2:1).
H3CO
OCH3
OCH3
H5
S
Y
H3a
N
H3
X
N
N
3-(4-Chlorophenyl)-5-(3,4,5-trimethoxyphenyl)-2-phenyl-6-p-tolyl-3,3a,5,6-tetrahydro-2H-pyrazolo-
o
1
[3,4-d]thiazole (4a). Light yellow crystals; yield 49 %; mp. 143 C; H-NMR δ: 2.31 (s, 3H, CH3),
3.72 (s, 9H, OCH3), 4.58 (d, J= 11.0 Hz, 1H, 3-CH), 5.82 (d, J= 11.0 Hz, 1H, 3a-CH), 6.01 (s, 1H, 5-
CH), 6.90-7.13 (m, 7H, aromatic), 7.17-7.38 (m, 4H, aromatic), 7.45-7.48 (m, 2H, aromatic), 7.64-7.77
(m, 2H, aromatic) ppm; FT-IR: 3005-3011 (aromatic), 1598 (C=N), 1256 (C-O) cm-1; Anal. Calcd. for
C32H30ClN3O3S (572.12): C, 67.18; H, 5.29; N, 7.34; S, 5.60. Found: C, 67.23; H, 5.21; N, 7.31; S,
5.57; MS: m/z 572.
3,6-Bis(4-Chlorophenyl)-5-(3,4,5-trimethoxyphenyl)-2-phenyl-3,3a,5,6-tetrahydro-2H-pyrazolo[3,4-
d]thiazole (4b). Yellow crystals; yield 51 %; mp. 152 oC; 1H-NMR δ: 3.73 (s, 9H, OCH3), 4.52 (d, J=
11.0 Hz, 1H, 3-CH), 5.79 (d, J= 11.0 Hz, 1H, 3a-CH), 5.99 (s, 1H, 5-CH), 6.92-7.12 (m, 7H,
aromatic), 7.18-7.37 (m, 4H, aromatic), 7.46-7.51 (m, 2H, aromatic), 7.71-7.81 (m, 2H, aromatic) ppm;
FT-IR: 3005-3010 (aromatic), 1596 (C=N), 1248 (C-O) cm-1; Anal. Calcd. for C31H27Cl2N3O3S
(592.54): C, 62.83; H, 4.59; N, 7.09; S, 5.41. Found: C, 62.84; H, 4.61, N: 7.11, S: 5.43; MS: m/z 593.
3-(4-Chlorophenyl)-5-(3,4,5-trimethoxyphenyl)-2-phenyl-6-(4-phenoxyphenyl)-3,3a,5,6-tetrahydro-
o
1
2H-pyrazolo[3,4-d]thiazole (4c). Yellow crystals; yield 62 %; mp. 151 C; H-NMR δ: 3.71 (s, 9H,
OCH3), 4.56 (d, J= 11.0 Hz, 1H, 3-CH), 5.82 (d, J= 11.0 Hz, 1H, 3a-CH), 6.03 (s, 1H, 5-CH), 6.92-
7.11 (m, 12H, aromatic), 7.17-7.23 (m, 4H, aromatic), 7.39-7.52 (m, 2H, aromatic), 7.63-7.71 (m, 2H,
aromatic) ppm; FT-IR: 3002-3011 (aromatic), 1598 (C=N), 1250 (C-O) cm-1; Anal. Calcd. for
C37H32ClN3O4S (650.19): C: 68.34, H: 4.96, N, 6.46, S: 4.93. Found: C, 68.37; H, 4.98, N: 6.47, S:
4.97; MS: m/z 650.
3-(4-Chlorophenyl)-6-(4-methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2-phenyl-3,3a,5,6-tetrahydro-
o
1
2H-pyrazolo[3,4-d]thiazole (4d). Light yellow crystals; yield 49 %; mp. 143 C; H-NMR δ: 3.61 (s,

Molecules 2007, 12
2158
3H, OCH3), 3.72 (s, 9H, OCH3), 4.58 (d, J= 11.0 Hz, 1H, 3-CH), 5.81 (d, J= 11.0 Hz, 1H, 3a-CH),
6.05 (s, 1H, 5-CH), 6.90-7.08 (m, 7H, aromatic), 7.17-7.38 (m, 4H, aromatic), 7.47-7.52 (m, 2H,
aromatic), 7.68-7.81 (m, 2H, aromatic) ppm; FT-IR: 3000-3010 (aromatic), 1602 (C=N), 1256 (C-O)
cm-1; Anal. Calcd. for C32H30ClN3O4S (588.12): C: 65.35, H: 5.14, N, 7.15, S: 5.45. Found: C, 65.37;
H, 5.16, N: 7.19, S: 5.49; MS: m/z 588.
3-(4-Chlorophenyl)-6-(4-ethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-2-phenyl-3,3a,5,6-tetrahydro-2H-
pyrazolo[3,4-d]thiazole (4e). Yellow crystals; yield 41 %; mp. 138 oC; 1H-NMR δ: 1.23-1.37 (t, J= 7.2
Hz, 3H, CH3), 3.71 (s, 9H, OCH3), 3.91-3.95 (q, J= 7.2 Hz, 2H, OCH2), 4.58 (d, J= 11.0 Hz, 1H, 3-
CH), 5.82 (d, J= 11.0 Hz, 1H, 3a-CH), 6.07 (s, 1H, 5-CH), 6.92-7.11 (m, 7H, aromatic), 7.17-7.39 (m,
4H, aromatic), 7.47-7.52 (m, 2H, aromatic), 7.68-7.81 (m, 2H, aromatic) ppm; FT-IR: 3000-3009
(aromatic), 1599 (C=N), 1245 (C-O) cm-1; Anal. Calcd. for C33H32ClN3O4S (602.15): C: 65.82, H:
5.36, N, 6.98, S: 5.33. Found: C, 65.84; H, 5.37, N: 6.99, S: 5.38; MS: m/z 602.
5-(3,4,5-Trimethoxyphenyl)-3-(4-dimethylaminophenyl)-2-phenyl-6-p-tolyl-3,3a,5,6-tetrahydro-2H-
pyrazolo[3,4-d]thiazole (4f). Yellow crystals; yield 51 %; mp. 161 oC; 1H-NMR δ: 2.32 (s, 3H, CH3),
2.85 (s, 6H, CH3), 3.76 (s, 9H, OCH3), 4.56 (d, J= 11.0 Hz, 1H, 3-CH), 5.81 (d, J= 11.0 Hz, 1H, 3a-
CH), 6.02 (s, 1H, 5-CH), 6.86-7.21 (m, 11H, aromatic), 7.30-7.51 (m, 4H, aromatic) ppm; FT-IR:
3004-3010 (aromatic), 1600 (C=N), 1246 (C-O) cm-1; Anal. Calcd. for C34H36N4O3S (580.75): C:
70.32, H: 6.25, N: 9.65, S: 5.52. Found: C, 70.34; H, 6.27, N: 9.67, S: 5.55; MS: m/z 581.
6-(4-Chlorophenyl)-5-(3,4,5-trimethoxyphenyl)-3-(4-dimethylaminophenyl)-2-phenyl-3,3a,5,6-tetra-
hydro-2H-pyrazolo[3,4-d]thiazole (4g). Yellow crystals; yield 38 %; mp. 150 oC; 1H-NMR δ: 2.89 (s,
6H, CH3), 3.76 (s, 9H, OCH3), 4.57 (d, J= 11.0 Hz, 1H, 3-CH), 5.81 (d, J= 11.0 Hz, 1H, 3a-CH), 6.05
(s, 1H, 5-CH), 6.83-7.26 (m, 11H, aromatic), 7.27-7.53 (m, 4H, aromatic) ppm; FT-IR: 3000-3008
(aromatic), 1600 (C=N), 1257 (C-O) cm-1; Anal. Calcd. for C33H33 ClN4O3S (601.16): C: 65.93, H:
5.53, N: 9.32, S: 5.33 Found: C, 65.97; H, 5.57, N: 9.37, S: 5.38; MS: m/z 601.
5-(3,4,5-Trimethoxyphenyl)-3-(4-dimethylaminophenyl)-6-(4-phenoxyphenyl)-2-phenyl-3,3a,5,6-tetra-
hydro-2H-pyrazolo[3,4-d]thiazole (4h). Yellow crystals; yield 38 %; mp. 155 oC; 1H-NMR δ: 2.89 (s,
6H, CH3), 3.81 (s, 9H, OCH3), 4.56 (d, J= 11.0 Hz, 1H, 3-CH), 5.81 (d, J= 11.0 Hz, 1H, 3a-CH), 6.02
(s, 1H, 5-CH), 6.86-7.21 (m, 16H, aromatic), 7.30-7.51 (m, 4H, aromatic) ppm; FT-IR: 3004-3010
(aromatic), 1598 (C=N), 1258 (C-O) cm-1; Anal. Calcd. for C39H38 N4O4S (658.82): C: 71.10, H: 5.81,
N: 8.50, S: 4.87 Found: C: 71.17; H, 5.83, N: 8.52, S:4.90; MS: m/z 659.
6-(4-Methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-3-(4-dimethylaminophenyl)-2-phenyl-3,3a,5,6-tetra-
o
1
hydro-2H-pyrazolo[3,4-d]thiazole (4i). Yellow crystals; yield 42 %; mp. 158 C; H-NMR δ: 2.83 (s,
6H, CH3), 3.55 (s, 3H, OCH3), 3.80 (s, 9H, OCH3), 4.56 (d, J= 11.0 Hz, 1H, 3-CH), 5.81 (d, J= 11.0
Hz, 1H, 3a-CH), 6.01 (s, 1H, 5-CH), 6.91-7.21 (m, 11H, aromatic), 7.29-7.53 (m, 4H, aromatic) ppm;
FT-IR: 3002-3011 (aromatic), 1596 (C=N), 1245 (C-O) cm-1; Anal. Calcd. for C34H36 N4O4S (596.75):
C: 68.43, H: 6.08, N: 9.39, S: 5.37 Found: C: 68.45; H, 6.11, N: 9.34, S:5.39; MS: m/z 597.

Molecules 2007, 12
6-(4-Ethoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-3-(4-dimethylaminophenyl)-2-phenyl-3,3a,5,6-tetra-
2159
o
1
hydro-2H-pyrazolo[3,4-d]thiazole (4j). Yellow crystals; yield 41 %; mp. 143 C; H-NMR δ: 1.23-
1.37 (t, J= 7.2 Hz, 3H, CH3), 2.81 (s, 6H, CH3), 3.83 (s, 9H, OCH3), 3.91-3.95 (q, J= 7.2 Hz, 2H,
OCH2), 4.58 (d, J= 11.0 Hz, 1H, 3-CH), 5.81 (d, J= 11.0 Hz, 1H, 3a-CH), 6.03 (s, 1H, 5-CH), 6.89-
7.23 (m, 11H, aromatic), 7.29-7.53 (m, 4H, aromatic) ppm; FT-IR: 3000-3007 (aromatic), 1600 (C=N),
1249 (C-O) cm-1; Anal. Calcd. for C35H38N4O4S (610.77): C: 68.83, H: 6.27, N: 9.17, S: 5.25. Found:
C: 68.85; H, 6.29, N: 9.20, S: 5.29; MS: m/z 611.
References
1. Capan, G.; Ulusoy, N.; Ergenc, N.; Kiraz, M. New 6-phenylimidazo[2,1-b]thiazole derivatives:
Synthesis and antifungal activity. Monatsh. Chem.
, 130, 1399-1407.
1999
2. Vigorita, M. G.; Ottana, R.; Monforte, F.; Maccari, R.; Trovato, A.; Monforte, M. T.; Taviano, M.
F. Synthesis and antiinflamatory, analgesic activity of 3,3’-(1,2-ethandiyl)-bis[2-aryl-4-
thiazolidinone] chiral compounds. Part 10. Bioorg. Med. Chem. Lett. 2001, 11, 2791-2794.
3. Kavitha, C. V.; Basappa, S.; Nanjunda, S.; Mantelingu, K.; Doreswamy, S.; Sridhar, M. A.;
Prasad, J. S.; Rangappa, K. S. Synthesis os new bioactive venlafaxine analogs: Novel thiazolidin-
4-ones as antimicrobials. Bioorg. Med. Chem. 2006, 14, 2290-2299.
4. Ottana, R.; Maccari, R.; Barreca, M. L.; Bruno, G.; Rotondo, A.; Rossi, A.; Chiricosta, G.; Di
Paola, R.; Sautebin, L.; Cuzzocrea, S.; Vigorita, M. G. 5-Arylidene-2-imino-4-thiazolidinones:
Design and synthesis of novel anti-inflammatory agents. Bioorg. Med. Chem. 2005, 13, 4243-
4252.
5. Kucukguzel, G.; Kocatepe, A.; De Clercq, E.; Sahin, F.; Gulluce, M. Synthesis and biological
activity of 4-thiazolidinones, thiosemicarbazides derived from diflunisal hydrazide. Eur. J. Med.
Chem. 2006, 41, 353-359.
6. Ocal, N.; Yolacan, C.; Kaban, S.; Leonor, Y.; Vargas, M.; Kouznetsov, V. J. Transformations of
Schiff bases derived from quinoline-8-carbaldehyde. Synthesis of C-8 substituted quinolines.
Heterocyclic. Chem. 2001, 38, 233-236.
7. Mendez, L. Y. V.; Kouznetsov, V.; Poveda, J. C.; Yolaçan, C.; Ocal, N.; Aydogan, F.
Transformations of 4-N-arylamino-4-(8-quinolinyl)-1-butenes and 3-aryl-2-(8-quinolinyl)-4-
thiazolidinones. Heterocycl. Commun. 2001, 7, 129-134.
8. Aydogan, F.; Ocal, N.; Turgut, Z.; Yolacan, C. Transformations of aldimines derived from
pyrrole- 2-carbaldehyde. Synthesis of thiazolidino-fused compounds. Bull. Korean Chem. Soc.
2001, 22, 476-480.
9. Ocal, N.; Aydogan, F.; Yolacan, C.; Turgut, Z. Synthesis of some furo-thiazolidine derivatives
starting from aldimines. J. Heterocycl. Chem. 2003, 40, 721-724.
10. Srivastava, T.; Haq, W.; Kati, S. B. Carbodiimide mediated synthesis of 4-thiazolidinones by one
pot three-component condensation. Tetrahedron 2002, 58, 7619-7624.
Sample Availability: Samples of the compounds are available from the authors.
© 2007 by MDPI (http://www.mdpi.org). Reproduction is permitted for noncommercial purposes.